Cerebrovascular AccidentSAMHPSDCNCT05039034
Screening and Management of High-risk Populations of Stroke in Dehui City
An observational study of Cerebrovascular Accident and Stroke, run by Yi Yang at 1 site in China.
Trial summary
This epidemiological survey is to analyze the prevalence rate of stroke and exposure rate of risk factors in sampling population aged 40 years and over (born before December 31,1975) in Dehui City, to provide scientific basis for pertinent prevention and control of stroke in Jilin Province, and to provide valuable… Read more about this study
- Who is it for?
- Ages 40 years and olderHealthy volunteers can take part
- Conditions the study is for
- Cerebrovascular Accident, Stroke, Hypertension
- What is being tested?
- Advice according to primary prevention guidelines on stroke of China
- How many people
- 4,100 participants
- Where
- 1 siteChina
- Study dates
- 1 Jan 2016to 31 Mar 2017
- How long will I take part?
- 3 Years
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 40 years and older
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: Target population aged 40 years and over (born before December 31,1975) was selected from Dehui City by means of group sampling.
Who may be able to join
- Aged 40 years and over in Dehui City
- Willing to participate in the study and follow-up visits
- Signed an informed consent
Who cannot join
- Life expectancy<3 years
- Unwilling to participate in the study and follow-up visits
- Living away from Dehui City over 6 months
- Unable to cooperate with examination and questionnaire due to mental disease
Trial locations and contacts
1 site in 1 country.
About this study
This epidemiological survey is to analyze the prevalence rate of stroke and exposure rate of risk factors in sampling population aged 40 years and over (born before December 31,1975) in Dehui City, to provide scientific basis for pertinent prevention and control of stroke in Jilin Province, and to provide valuable data for the high-risk groups to carry out regular follow-up and standardized management.
- Conditions
- Cerebrovascular Accident, Stroke, Hypertension, Diabetes Mellitus, Dyslipidemias
- Being tested
- Advice according to primary prevention guidelines on stroke of China
- Keywords
- Stroke/epidemiology, Stroke/prevention and control, Risk Factors, Cognition, Surveys and Questionnaires
- Medical subject headings
- Stroke, Hypertension, Diabetes Mellitus, Dyslipidemias
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Advice according to primary prevention guidelines on stroke of ChinaOther
| Study group | Role | What they receive |
|---|---|---|
| Low-risk Group | Low-risk Group is defined as the population with <3 risk factors (hypertension, dyslipidemia or dyslipoproteinemia, diabetic mellitus, atrial fibrillation or valvular heart disease, smoking, lack of exercise or light manual labor, overweight or obesity and family history of stroke), but without chronic disease (hypertension, diabetic mellitus, atrial fibrillation or valvular heart disease). Receives: Other: Advice according to primary prevention guidelines on stroke of China | |
| Mediate-risk Group | Mediate-risk Group is defined as the population with <3 risk factors (hypertension, dyslipidemia or dyslipoproteinemia, diabetic mellitus, atrial fibrillation or valvular heart disease, smoking, lack of exercise or light manual labor, overweight or obesity and family history of stroke), but meanwhile suffer from chronic disease (hypertension, diabetic mellitus, atrial fibrillation or valvular heart disease). Receives: Other: Advice according to primary prevention guidelines on stroke of China | |
| High-risk Group | High-risk Group is defined as the population with ≥3 risk factors (hypertension, dyslipidemia or dyslipoproteinemia, diabetic mellitus, atrial fibrillation or valvular heart disease, smoking, lack of exercise or light manual labor, overweight or obesity and family history of stroke), or population with history of stroke or/and transient ischemic attack. Receives: Other: Advice according to primary prevention guidelines on stroke of China |
What is being measured
The primary outcome is the main question the study is designed to answer.
Prevalence rate of stroke
The proportion of stroke in the general population.
Measured: 4 months
Prevalence rate of hypertension
The proportion of hypertension in the general population.
Measured: 4 months
Prevalence rate of diabetes mellitus
The proportion of diabetes mellitus in the general population.
Measured: 4 months
Prevalence rate of dyslipidemia
The proportion of dyslipidemia in the general population.
Measured: 4 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted9 Sep 2021
- Study start1 Jan 2016
- Primary completion31 Mar 2016
- Study completion31 Mar 2017
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Cerebrovascular AccidentStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Other
- Time perspective
- Cross-sectional
- Enrolment
- 4,100 participants (actual)
- Target duration
- 3 Years
Sponsor and investigators
- Lead sponsor
- Yi Yang
- Sponsor type
- University, hospital or other
- Collaborators
- Dehui People's Hospital
- Responsible party
- Sponsor-investigator, Yi Yang, The First Hospital of Jilin University
- Investigators
- Yi Yang, M.D. Ph.D., Study chair, The First Hospital of Jilin UniversityYing-Qi Xing, M.D. Ph.D., Study director, The First Hospital of Jilin UniversityZhen-Ni Guo, M.D., Study director, The First Hospital of Jilin UniversityFu-Liang Zhang, M.D., Principal investigator, The First Hospital of Jilin UniversityHao-Yuan Liu, M.D., Principal investigator, The First Hospital of Jilin University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05039034
- Sponsor's protocol ID
- SMDC
- Acronym
- SAMHPSDC
- Status last verified
- Aug 2021
- First submitted
- 30 Aug 2021
- Last updated
- 9 Sep 2021
- Results posted
- No
- Data monitoring committee
- Yes
Study at a glance
From the registry record, last updated by the sponsor on 9 Sep 2021. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Screening and Management of High-risk Populations of Stroke in Dehui City
- ClinicalTrials.gov ID
- NCT05039034
- Acronym / sponsor ID
- SAMHPSDC / SMDC
- Conditions
- Cerebrovascular Accident, Stroke, Hypertension, Diabetes Mellitus, Dyslipidemias
- Keywords
- Stroke/epidemiology, Stroke/prevention and control, Risk Factors, Cognition, Surveys and Questionnaires
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 4,100 participants (actual)
- Lead sponsor
- Yi YangUniversity, hospital or other
- Collaborators
- Dehui People's Hospital
- Study start
- 1 Jan 2016 (actual)
- Primary completion
- 31 Mar 2016 (actual)
- Study completion
- 31 Mar 2017 (actual)
- First posted
- 9 Sep 2021 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This epidemiological survey is to analyze the prevalence rate of stroke and exposure rate of risk factors in sampling population aged 40 years and over (born before December 31,1975) in Dehui City, to provide scientific basis for pertinent prevention and control of stroke in Jilin Province, and to provide valuable data for the high-risk groups to carry out regular follow-up and standardized management.
Study design
- Observational model
- Other
- Time perspective
- Cross-sectional
- Target follow-up
- 3 Years
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| Low-risk Group | – | Other: Advice according to primary prevention guidelines on stroke of ChinaLow-risk Group is defined as the population with <3 risk factors (hypertension, dyslipidemia or dyslipoproteinemia, diabetic mellitus, atrial fibrillation or valvular heart disease, smoking, lack of exercise or light manual labor, overweight or obesity and family history of stroke), but without chronic disease (hypertension, diabetic mellitus, atrial fibrillation or valvular heart disease). |
| Mediate-risk Group | – | Other: Advice according to primary prevention guidelines on stroke of ChinaMediate-risk Group is defined as the population with <3 risk factors (hypertension, dyslipidemia or dyslipoproteinemia, diabetic mellitus, atrial fibrillation or valvular heart disease, smoking, lack of exercise or light manual labor, overweight or obesity and family history of stroke), but meanwhile suffer from chronic disease (hypertension, diabetic mellitus, atrial fibrillation or valvular heart disease). |
| High-risk Group | – | Other: Advice according to primary prevention guidelines on stroke of ChinaHigh-risk Group is defined as the population with ≥3 risk factors (hypertension, dyslipidemia or dyslipoproteinemia, diabetic mellitus, atrial fibrillation or valvular heart disease, smoking, lack of exercise or light manual labor, overweight or obesity and family history of stroke), or population with history of stroke or/and transient ischemic attack. |
Who may qualify
- Ages
- 40 years and older
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- Target population aged 40 years and over (born before December 31,1975) was selected from Dehui City by means of group sampling.
Key inclusion criteria (3 listed)
- Aged 40 years and over in Dehui City
- Willing to participate in the study and follow-up visits
- Signed an informed consent
Key exclusion criteria (4 listed)
- Life expectancy<3 years
- Unwilling to participate in the study and follow-up visits
- Living away from Dehui City over 6 months
- Unable to cooperate with examination and questionnaire due to mental disease
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Advice according to primary prevention guidelines on stroke of China | Other | High-risk Group, Low-risk Group, Mediate-risk Group |
Primary outcome
Prevalence rate of stroke
Time frame: 4 months
The proportion of stroke in the general population.
Prevalence rate of hypertension
Time frame: 4 months
The proportion of hypertension in the general population.
Prevalence rate of diabetes mellitus
Time frame: 4 months
The proportion of diabetes mellitus in the general population.
Prevalence rate of dyslipidemia
Time frame: 4 months
The proportion of dyslipidemia in the general population.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 9 Sep 2021.
Related trials for Cerebrovascular Accident
Not yet recruiting
Temporal Interference Stimulation for Upper-Limb Motor Recovery in Early Subacute Stroke
Acute Ischemic Stroke
RecruitingObservational study
ELATE Study: Evaluating Large-vessel Acute Thrombectomy in Extended Time Window
Acute Ichemic Stroke
Recruiting
Web-Based Tele-Rehabilitation Using Action Observation and Mirror Therapy for Subacute Stroke: A Randomized Controlled Trial
Stroke, Upper Extremity Paresis
Recruiting
Early Motor-Cognitive Integrative Training on Cognitive and Motor Performance in Patients With Aneurysmal Subarachnoid Hemorrhage
Subarachnoid Aneurysm Hemorrhage
Not yet recruiting
Selective Intra-Arterial Hypothermia After Endovascular Treatment for Acute Basilar Artery Occlusion
Acute Ischemic Stroke, Basilar Artery Occlusion
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Yi Yang, M.D. Ph.D. study chair
The First Hospital of Jilin University
Ying-Qi Xing, M.D. Ph.D. study director
The First Hospital of Jilin University
Zhen-Ni Guo, M.D. study director
The First Hospital of Jilin University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Cerebrovascular Accident and Stroke, run by Yi Yang at 1 site in China.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 9 Sep 2021. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Prevalence rate of stroke (time frame: 4 months). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Sep 2021.